PACB logo

Pacific Biosciences of California, Inc. (PACB)

Profile

Full Name

Pacific Biosciences of California, Inc.

Ticker

NASDAQ: PACB

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

October 27, 2010

Indexes

Not included

Website

https://www.pacb.com

Employees

575

Key Details

Price

$1.76(-1.12%)

Market Cap

$531.36M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$154.01M(-23.19% YoY)

Annual EPS

-$1.59(-31.28% YoY)

PE Ratio

-

Next earnings date

Feb 12, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.76
    PACB price is $1.76

    30-Day Relative Volume

    0.82
    PACB 30-day relative volume is 0.82

    Price Performance

    Price Most Recent Change

    -1.12%
    PACB price was down -1.12% on Nov 7, 2025

    Price YTD Change

    -3.83%
    PACB price is down -3.83% since January 1st

    Price 1-Year Change

    -28.16%
    PACB price is down -28.16% year-on-year

    Price 3-Year Change

    -79.1%
    PACB price is down -79.1% over the past 3 years

    Price Range

    Price All-Time High

    $53.69
    PACB price is currently -96.72% below its historical high of $53.69

    Price 3-Year Low

    $0.85
    PACB price is currently +107.06% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $531.36M
    PACB market cap is $531.36 million

    Market Cap 3-Year Change

    -72.09%
    PACB market cap is down -72.09% over the past 3 years

    Market Cap All-Time High

    $9.88B
    PACB market cap is currently -94.62% below its historical high of $9.88 billion

    Market Cap Sector Percentile

    63.52%
    PACB market cap is higher than 63.52% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +10.24%
    PACB shares outstanding is up +10.24% year-on-year

    Shares Outstanding 3-Year Change

    +33.52%
    PACB shares outstanding is up +33.52% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.75
    PACB beta is 1.75

    200-day SMA

    $1.37
    PACB price is currently +28.43% above its 200-day simple moving average

    50-day SMA

    $1.55
    PACB price is currently +13.78% above its 50-day simple moving average

    14-Day RSI

    48.37
    PACB 14-day relative strength index is 48.37

    Volume

    0.82
    PACB 30-day relative volume is 0.82

    ATR

    $0.17
    PACB average true range is $0.17

    10-day Historical Volatility

    137.86%
    PACB 10-day historical volatility is 137.86%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $154.01M
    PACB annual revenue is $154.01 million

    Revenue Analysts Estimate

    $160.22M
    PACB annual revenue is currently -3.87% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -23.19%
    PACB annual revenue is down -23.19% year-on-year

    Revenue Sector Percentile

    71.64%
    PACB annual revenue is higher than 71.64% of companies in Healthcare sector

    EPS

    EPS

    -$1.59
    PACB annual earnings per share is -$1.59

    EPS Analysts Estimate

    -$0.56
    PACB annual earnings per share is currently -185.04% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -31.28%
    PACB annual earnings per share is down -31.28% year-on-year

    EPS Sector Percentile

    44.25%
    PACB annual earnings per share is higher than 44.25% of companies in Healthcare sector

    Profit

    Gross Profit

    $37.28M
    PACB annual gross profit is $37.28 million

    Gross Margin

    15.37%
    PACB annual gross profit margin is 15.37%

    Operating Profit

    -$290.66M
    PACB annual operating income is -$290.66 million

    Operating Margin

    -188.73%
    PACB annual operating profit margin is -188.73%

    Net Income

    -$309.85M
    PACB annual net profit is -$309.85 million

    Net Margin

    -200.40%
    PACB annual net profit margin is -200.40%

    Expenses

    Total Expenses

    $444.68M
    PACB annual total expenses is $444.68 million

    Operating Expenses

    $327.94M
    PACB annual total operating expenses is $327.94 million

    Cost Of Goods Sold

    $130.34M
    PACB annual cost of goods sold is $130.34 million

    Selling, General & Administrative Expenses

    $175.02M
    PACB annual SG&A is $175.02 million

    Depreciation & Amortization

    $53.35M
    PACB annual D&A is $53.35 million

    Interest Expense

    $0.00
    PACB annual interest expense is $0.00

    Income Tax

    $316.00K
    PACB annual income tax is $316.00 thousand

    EBIT & EBITDA

    EBIT

    -$294.92M
    PACB annual earnings before interest & taxes is -$294.92 million

    EBITDA

    -$276.92M
    PACB annual EBITDA is -$276.92 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $1.26B
    PACB annual total assets is $1.26 billion

    Non Current Assets

    $764.77M
    PACB annual long term assets is $764.77 million

    Current Assets

    $495.68M
    PACB annual total current assets is $495.68 million

    Cash and Cash Equivalents

    $390.62M
    PACB annual cash & cash equivalents is $390.62 million

    Accounts Receivable

    $27.52M
    PACB annual accounts receivable is $27.52 million

    Inventory

    $58.76M
    PACB annual inventory is $58.76 million

    Liabilities

    Total Liabilities

    $753.85M
    PACB annual total liabilities is $753.85 million

    Long Term Liabilities

    $687.55M
    PACB annual total long term liabilities is $687.55 million

    Current Liabilities

    $66.30M
    PACB annual current liabilities is $66.30 million

    Accounts Payable

    $16.59M
    PACB annual accounts payable is $16.59 million

    Debt

    Total Debt

    $674.63M
    PACB annual total debt is $674.63 million

    Total Debt 1-Year Change

    -27.76%
    PACB annual total debt is down -27.76% year-on-year

    Long Term Debt

    $662.41M
    PACB annual long term debt is $662.41 million

    Short Term Debt

    $12.23M
    PACB annual short term debt is $12.23 million

    Equity & Capital

    Shareholders Equity

    $506.59M
    PACB annual stockholders equity is $506.59 million

    Book Value

    $506.59M
    PACB annual book value is $506.59 million

    Retained Earnings

    -$2.15B
    PACB annual retained earnings is -$2.15 billion

    Working Capital

    $429.38M
    PACB annual working capital is $429.38 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$206.06M
    PACB annual cash from operations is -$206.06 million

    Cash From Operations 1-Year Change

    +20.49%
    PACB annual cash from operations is up +20.49% year-on-year

    Cash From Investing

    $124.00M
    PACB annual cash from investing is $124.00 million

    Cash From Investing 1-Year Change

    +2593.4%
    PACB annual cash from investing is up +2593.4% year-on-year

    Cash From Financing

    -$42.99M
    PACB annual cash from financing is -$42.99 million

    Cash From Financing 1-Year Change

    -139.48%
    PACB annual cash from financing is down -139.48% year-on-year

    CAPEX

    CAPEX

    $6.19M
    PACB annual capital expenditures is $6.19 million

    CAPEX 1-Year Change

    -30.02%
    PACB annual capital expenditures is down -30.02% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$212.25M
    PACB annual free cash flow is -$212.25 million

    Free Cash Flow 1-Year Change

    +20.81%
    PACB annual free cash flow is up +20.81% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    15.37%
    PACB annual gross profit margin is 15.37%

    Operating Margin

    -188.73%
    PACB annual operating profit margin is -188.73%

    Net Margin

    -200.40%
    PACB annual net profit margin is -200.40%

    ROA & ROE

    ROA

    -20.61%
    PACB annual return on assets is -20.61%

    ROE

    -51.30%
    PACB annual return on equity is -51.30%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    PACB price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    PACB price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    14.72
    PACB price to book ratio is 14.72

    PB Ratio Sector Percentile

    92.44%
    PACB price to book ratio is higher than 92.44% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    3.44
    PACB price to sales ratio is 3.44

    PS Ratio Sector Percentile

    48.65%
    PACB price to sales ratio is higher than 48.65% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $932.78M
    PACB enterprise value is $932.78 million

    Enterprise Value Sector Percentile

    70.84%
    PACB enterprise value is higher than 70.84% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    PACB EV/EBITDA value is unknown

    EV/EBITDA Sector Percentile

    -
    PACB EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    7.48
    PACB annual current ratio is 7.48

    Quick Ratio

    6.59
    PACB annual quick ratio is 6.59

    Leverage

    Debt To Equity

    1.33
    PACB annual debt to equity ratio is 1.33

    Interest Coverage Ratio

    -
    PACB annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    PACB piotroski f-score value is unknown

    Altman Z-Score

    -2.21
    PACB altman z-score is -2.21

    Analyst ratings

    Recent major analysts updates

    Aug 11, 25 Piper Sandler
    Neutral
    Jun 25, 25 Barclays
    Equal-Weight
    May 15, 25 Stephens & Co.
    Overweight
    May 15, 25 Piper Sandler
    Neutral
    Apr 10, 25 Canaccord Genuity
    Buy
    Mar 25, 25 Scotiabank
    Sector Outperform
    Feb 20, 25 Piper Sandler
    Neutral
    Feb 18, 25 Stephens & Co.
    Overweight
    Feb 18, 25 Goldman Sachs
    Neutral
    Feb 14, 25 Stephens & Co.
    Overweight

    Institutional Ownership

    Screeners with PACB included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Pacific Biosciences of California, Inc.?
    • Does Pacific Biosciences of California, Inc. pay dividends?
    • What sector is Pacific Biosciences of California, Inc. in?
    • What industry is Pacific Biosciences of California, Inc. in?
    • What country is Pacific Biosciences of California, Inc. based in?
    • When did Pacific Biosciences of California, Inc. go public?
    • Is Pacific Biosciences of California, Inc. in the S&P 500?
    • Is Pacific Biosciences of California, Inc. in the NASDAQ 100?
    • Is Pacific Biosciences of California, Inc. in the Dow Jones?
    • When was Pacific Biosciences of California, Inc.'s last earnings report?
    • When does Pacific Biosciences of California, Inc. report earnings?

    What is the ticker symbol for Pacific Biosciences of California, Inc.?

    The ticker symbol for Pacific Biosciences of California, Inc. is NASDAQ:PACB

    Does Pacific Biosciences of California, Inc. pay dividends?

    No, Pacific Biosciences of California, Inc. does not pay dividends

    What sector is Pacific Biosciences of California, Inc. in?

    Pacific Biosciences of California, Inc. is in the Healthcare sector

    What industry is Pacific Biosciences of California, Inc. in?

    Pacific Biosciences of California, Inc. is in the Medical Devices industry

    What country is Pacific Biosciences of California, Inc. based in?

    Pacific Biosciences of California, Inc. is headquartered in United States

    When did Pacific Biosciences of California, Inc. go public?

    Pacific Biosciences of California, Inc.'s initial public offering (IPO) was on October 27, 2010

    Is Pacific Biosciences of California, Inc. in the S&P 500?

    No, Pacific Biosciences of California, Inc. is not included in the S&P 500 index

    Is Pacific Biosciences of California, Inc. in the NASDAQ 100?

    No, Pacific Biosciences of California, Inc. is not included in the NASDAQ 100 index

    Is Pacific Biosciences of California, Inc. in the Dow Jones?

    No, Pacific Biosciences of California, Inc. is not included in the Dow Jones index

    When was Pacific Biosciences of California, Inc.'s last earnings report?

    Pacific Biosciences of California, Inc.'s most recent earnings report was on November 5, 2025

    When does Pacific Biosciences of California, Inc. report earnings?

    The next expected earnings date for Pacific Biosciences of California, Inc. is February 12, 2026
    On this page